As in all stock investments, SALES is the ultimate difference maker. Yes, signing deals is the start of that, so we will probably get a bump up from news of that because signing deals is a precursor for SALES. Getting FDA OK for RecoveryRX was great, but NOTHING like confirmation of deals signed that are in direct correlation with SALES. That (signing deala) in no way, can be perceived as anything but positive. So I see a nice little pop in stock price.
BUT we will need SALES to show up on the income statement to see that rise in price sustained and hopefully continue. That is why all wait anxiously for quarterly reports of the companies they have invested in. Financials are the premier information for investors. News moves stock price temporarily but when SALES and NET INCOME (+ or -) are reported, that is when the stock price justifies company performance based on those numbers. Thus we see crappy triple zero stock price after crappy last quarter numbers.
Market Data 
Markets 
